# A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine

> **NCT02856854** · PHASE1 · COMPLETED · sponsor: **Embera NeuroTherapeutics, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Cocaine Use Disorder

## Interventions

- **DRUG:** EMB-001
- **DRUG:** Placebo
- **DRUG:** Cocaine IV
- **DRUG:** Saline IV

## Key facts

- **NCT ID:** NCT02856854
- **Lead sponsor:** Embera NeuroTherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-02-17
- **Final completion:** 2017-07-25
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02856854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02856854, "A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02856854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*